Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

voisybay 102 posts  |  Last Activity: Sep 1, 2015 1:33 PM Member since: Dec 29, 2010
  • voisybay voisybay Jul 13, 2015 8:27 AM Flag

    thanks for your usual sightful insight----good luck with AVXL next week also---I've been long NVIV for some time but new to AVXL-hope it has early positive results next wek

  • Reply to

    Doctor's Opinion.....

    by elcaribes Jul 12, 2015 9:06 AM
    voisybay voisybay Jul 12, 2015 9:58 AM Flag

    I bet that once patient #4/#5 are enrolled and show similar great results that the mainstream media (60 minutes etc) will be spreading the word on what is taking place. The recent "Today" show report was a start but In Vivo spoke to the FDA before it was aired to see if it was okay to proceed with it--in fact other than a small "tweezer" like device that held the scaffold that had "In Vivo" on it-the company wasn't mentioned at all

  • voisybay voisybay Jul 12, 2015 9:42 AM Flag

    remain long on AVXL--not sure how to check this---but has there been a lot of "insider" buying leading up to 7/22 recently? has Dr. Missling been accumulating more shares?

  • Reply to

    Read the title 7/22 presentation...

    by ranger43a Jul 5, 2015 12:45 PM
    voisybay voisybay Jul 11, 2015 6:34 AM Flag

    Dr. Missling’s (CEO) previously was in charge of financial planning on all aspects of financial strategy and M&A during his time at Aventis (now Sanofi (SNY))--I bet SNY is also going to be watching the presentation on July 22 too---also if AXON (also working on an AZ drug-phase 3) had a big IPO for a drug not still marketed-won't AVXL also get a big "boost" if 2-73 (and ultimately the reported results in the fall) shows efficacy

  • Reply to

    longs, u should stay strong

    by halifax.investor Jul 10, 2015 8:55 PM
    voisybay voisybay Jul 11, 2015 6:19 AM Flag

    Maybe "immansidope" is trying out a new name? or perhaps its his "evil twin brother"

  • Reply to

    Perrin Has the Helm

    by nomosci Jul 10, 2015 3:27 PM
    voisybay voisybay Jul 10, 2015 4:15 PM Flag

    That was my thought-
    Good old Frankie dumping more of his shares--maybe needs more money to get PixarBio up and running prior to its IPO
    Also wonder if some announcement(s) are coming up shortly about the enrollment of Patient #4/#5--maybe manipulation by "driving" the price down (dumping shares) in anticipation of this event in order to "ride" cheaper shares back up

  • voisybay by voisybay Jul 10, 2015 9:06 AM Flag

    both focusing on Alzhemeirs disease (AMBS supposedly has early diagnostic test that still hasn't been marketed)-own positions in both (certainly more in AVXL)--curious if anyone else covering their bets by owning both? which one is the more sure bet in the long run?

    Sentiment: Strong Buy

  • Reply to

    NVIV

    by prospern23 Jul 6, 2015 12:05 PM
    voisybay voisybay Jul 7, 2015 9:03 AM Flag

    Looking at AVXL--noting some "poster presentation" week of July 20 may drive pps--will do further DD but also very interested in their Alzheimer's drug

  • Reply to

    +$0.79 after hours

    by whiskeysausage Jul 6, 2015 6:10 PM
    voisybay voisybay Jul 6, 2015 6:36 PM Flag

    Still can't believe we haven't reached the level that was reached prior to the ouster of Reynolds in August 2013 ($6.24 x 4= ~$25)--that price was generated by nothing but "hype"--now we have clear/documented proof the scaffold works (and far better than what this "safety" trial was supposed to show)--I think its going to take the completion of the enrollment of patient #4/#5 and their follow-up results to really convince skeptics

  • Reply to

    3 for 3

    by alexsissy Jul 6, 2015 8:33 AM
    voisybay voisybay Jul 6, 2015 8:44 AM Flag

    As I recall there were many "naysayers" who were saying that Patient #3 had the scaffold inserted too late after injury to hope there would much (if any) improvement--
    --well---so much for that---this is incredible when you consider that many spinal cord injured patients will arrive in the ER with multiple life threatening injuries (ie motor vehicle accidents etc)--hence these patients can spend time being stabilized before the scaffold is inserted and benefit will still be achieved--this is a real "game breaker"
    you can be sure the FDA will now work very closely with In Vivo to get the "scaffold + neural stem cell" trial designed--probably a lot sooner than expected too

  • Reply to

    So much for their improvement being a matter of

    by aretxen Jul 6, 2015 8:14 AM
    voisybay voisybay Jul 6, 2015 8:23 AM Flag

    I expect the pivotal study will not have to involve 50+ patients--I just hope patient #4, #5 get enrolled ASAP--once benefit is confirmed with these last two patients (as it will)-the pivotal study will be expediated--
    I'm sure the FDA will be pressured to get this to market (especially since there never has been anything to offer acute spinal cord patients that offered any benefit)

    (and as a secondary benefit I'm sure we've heard the last from immansidope)

  • Reply to

    Robert Heary, M.D. is a very prolific author

    by regener8ve Jun 30, 2015 7:25 PM
    voisybay voisybay Jul 1, 2015 8:00 AM Flag

    I would have thought Dr.Theodore (neurosurgeon who implanted the scaffold in Jordan) would be anxious to do it again (especially after his excitement when reporting Jordan's initial results)-and with his centre being among the largest acute spinal injury centres he would be like a "hawk" screening patients who could possilbly fit the criteria to be Patient #4 or #5

  • Reply to

    Future

    by voisybay Jun 29, 2015 5:12 PM
    voisybay voisybay Jun 29, 2015 5:33 PM Flag

    sorry meant "pilot" study--if we can enroll the last 2 patients in the next month-we will look back on this one day "drop" as a great opportunity to buy more (wish I had more money to do so)

  • voisybay by voisybay Jun 29, 2015 5:12 PM Flag

    Juno Therapeutics is up 30% after hours after receiving a $1 billion upfront payment from Celgene---just wait-once the full pivitol study results from all 5 patients are reviewed-you can bet J & J/Stryker will be "pounding" on In Vivo's door to either form a partnership or a buyout (hopefully the former)

  • Reply to

    Mini Rant for Saturday

    by rc248 Jun 27, 2015 11:52 AM
    voisybay voisybay Jun 27, 2015 9:38 PM Flag

    why is the SA piece "fluff"--the article spells out the potential of all of SYN's pipeline--outlining what is going on and where in development each drug is at. Why is the potential FDA fast track of SYN-004 so far fetched? I am an internist in a large hospital and I see cases of C Diff colitis almost daily---if SYN's approach works it will revolutionize treatment of this scorge and prevent many deaths--especially in long term care facilities where the elderly are particularly vulnerable to this

    Sentiment: Strong Buy

  • Reply to

    Mini Rant for Saturday

    by rc248 Jun 27, 2015 11:52 AM
    voisybay voisybay Jun 27, 2015 9:32 PM Flag

    I invested in SYN because even if the Trimesta MRI results disappoint--they have SYN-004/010 and 005--each possibly being $billion dollar markets--?what would the potential pps be if all these drugs are successful??

  • Reply to

    Can't Wait For Seres to Come Crashing Down

    by jlukenjj Jun 26, 2015 10:33 PM
    voisybay voisybay Jun 27, 2015 1:35 PM Flag

    I work as an internist in a large hospital--I've seen patients die from hospital acquired CDiff infection---does that mean I bought SYN based on "hype"--NO-I've done my DD---this will save lives hence the likelihood SYN-004 will be "fast tracked"

  • Reply to

    Click "Bulb" just thinking .... Langer surely

    by aretxen Jun 26, 2015 9:04 AM
    voisybay voisybay Jun 26, 2015 9:11 AM Flag

    The last thing Dr. Langer has to do is "audition for a Nobel Prize"--his work completely speaks for itself-there are already positive results to report (Jordan/Jesi-Patient #1/#2)-my hope is that through his speech stem cell companies that are attending this conference will approach him (and any In Vivo staff that may be there) about a future partnership

  • Reply to

    Trimesta- the choice?

    by ugt.92251 Jun 24, 2015 4:51 PM
    voisybay voisybay Jun 26, 2015 6:35 AM Flag

    Financing is the only thing I worry about---I'll feel a lot better once a partnership is announced for Trimesta--that would provide more than enough cash to get all SYN pipeline drugs to approval

  • Reply to

    reason not to sell?

    by jimmybuffett830 Jun 25, 2015 3:13 PM
    voisybay voisybay Jun 26, 2015 6:25 AM Flag

    and as it has been pointed out--that all time high pps ($24,80) was based on nothing but "hype" from the former CEO (Reynolds)--there were no patients enrolled (or even close to being enrolled)-no uplisting at that time---Now we have patients enrolled (and demonstrating neurologic improvement) fully uplisted etc---if "hype" drove this to $24+ then these results/events should be driving the price far above this

    Sentiment: Strong Buy

NVIV
9.85+0.37(+3.90%)Sep 4 4:00 PMEDT